002693 *ST双成药业
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)0.8334.726-18.107-10.3031.811
总资产报酬率 ROA (%)0.4202.366-9.868-5.9201.021
投入资产回报率 ROIC (%)0.5042.870-12.064-7.2671.278

边际利润分析
销售毛利率 (%)62.35354.75056.03768.27267.867
营业利润率 (%)-1.0813.201-60.922-31.007-3.280
息税前利润/营业总收入 (%)6.8926.725-55.849-26.9130.832
净利润/营业总收入 (%)-1.2363.223-61.002-30.508-3.092

收益指标分析
经营活动净收益/利润总额(%)281.526112.42075.68257.871612.935
价值变动净收益/利润总额(%)-10.4127.0078.85150.845-52.175
营业外收支净额/利润总额(%)12.594-8.6330.040-0.255-1.470

偿债能力分析
流动比率 (X)0.6580.6670.8810.9660.790
速动比率 (X)0.4230.4520.4260.4350.585
资产负债率 (%)48.54749.07547.49035.55636.232
带息债务/全部投入资本 (%)38.00137.93637.54525.94329.673
股东权益/带息债务 (%)158.986159.953161.914279.148232.168
股东权益/负债合计 (%)104.970101.780105.681165.085155.585
利息保障倍数 (X)0.8481.780-10.958-6.7040.205

营运能力分析
应收账款周转天数 (天)92.83948.24726.67031.35730.819
存货周转天数 (天)338.687210.741363.927335.973245.989